Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
4(44%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
1
11%
Ph not_applicable
8
89%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution9 total trials
Phase 2Efficacy & side effects
1(11.1%)
N/ANon-phased studies
8(88.9%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

4

trials recruiting

Total Trials

9

all time

Status Distribution
Active(6)
Completed(2)
Other(1)

Detailed Status

Recruiting4
Not yet recruiting2
Completed2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
4
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (11.1%)
N/A8 (88.9%)

Trials by Status

not_yet_recruiting222%
recruiting444%
unknown111%
completed222%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
9